ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 2 filers reported holding ANI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $30,000 | -11.8% | 28,000 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +9.7% | 28,000 | 0.0% | 0.00% | – |
| Q1 2019 | $31,000 | +10.7% | 28,000 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | -6.7% | 28,000 | 0.0% | 0.00% | – |
| Q3 2018 | $30,000 | -6.2% | 28,000 | 0.0% | 0.00% | – |
| Q2 2018 | $32,000 | +3.2% | 28,000 | 0.0% | 0.00% | – |
| Q1 2018 | $31,000 | +675.0% | 28,000 | +600.0% | 0.00% | – |
| Q2 2017 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | -86.2% | 4,000 | -84.0% | 0.00% | – |
| Q4 2016 | $29,000 | +480.0% | 25,000 | +525.0% | 0.00% | – |
| Q3 2016 | $5,000 | -54.5% | 4,000 | -60.0% | 0.00% | – |
| Q2 2016 | $11,000 | +22.2% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -78.6% | 10,000 | -76.7% | 0.00% | – |
| Q4 2015 | $42,000 | +600.0% | 43,000 | +616.7% | 0.00% | – |
| Q3 2015 | $6,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 46,542 | $43,298,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $7,370,000 | 0.75% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $1,388,000 | 0.60% |
| Perceptive Advisors | 15,000,000 | $13,846,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $14,296,000 | 0.34% |
| LINDEN ADVISORS LP | 3,500,000 | $3,258,000 | 0.22% |
| Visium Asset Management, LP | 6,500,000 | $6,067,000 | 0.08% |
| ZAZOVE ASSOCIATES LLC | 1,750,000 | $1,625,000 | 0.08% |
| Investors Capital Advisory Services | 326,000 | $300,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,969,000 | $14,771,000 | 0.04% |